Orchestra BioMed Holdings, Inc. Sale of Stock, Consideration Received on Transaction
Orchestra BioMed Holdings, Inc. (OBIO) reported Sale of Stock, Consideration Received on Transaction of $5.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. sale of stock, consideration received on transaction for the quarter ending 2026-06-30 was $0.00.
- Orchestra BioMed Holdings, Inc. sale of stock, consideration received on transaction for the quarter ending 2026-03-31 was $5.86M.
- Orchestra BioMed Holdings, Inc. sale of stock, consideration received on transaction for the quarter ending 2024-12-31 was $0.00.
- Orchestra BioMed Holdings, Inc. sale of stock, consideration received on transaction for fiscal 2025 was $1.54M, a 89.74% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. sale of stock, consideration received on transaction for fiscal 2024 was $15.04M.
| Period end | Sale of Stock, Consideration Received on Transaction 0 month | Sale of Stock, Consideration Received on Transaction 3 month | Sale of Stock, Consideration Received on Transaction 6 month | Sale of Stock, Consideration Received on Transaction 9 month | Sale of Stock, Consideration Received on Transaction 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.86M 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | $5.86M 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | $1.54M 10-K · filed 2026-03-12 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $15.04M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $15.04M 10-Q · filed 2025-11-10 | ||||
| 2020-08-06 | $160.00M 10-K · filed 2023-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |